12/9/2019

Nystatin Oral Suspension

Products Affected - Description

- Nystatin oral suspension, Akorn, 100,000 units/mL, 473 mL bottle, NDC 50383-0587-16 - discontinued
- Nystatin oral suspension, Akorn, 100,000 units/mL, 60 mL bottle, NDC 50383-0587-66 - discontinued

Reason for the Shortage

- Akorn discontinued nystatin suspension in 2019.
- Pharmaceutical Associates, Inc. has nystatin suspension available.
- Precision Dose has nystatin suspension available.
- Vista Pharma has nystatin suspension available.
- Wockhardt USA has nystatin suspension available.

Available Products

- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 units/mL, 473 mL bottle, NDC 00121-0810-16
- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 units/mL, 5 mL container, 40 count, NDC 00121-4810-40
- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 units/mL, 5 mL container, 100 count, NDC 00121-4810-00
- Nystatin oral suspension, Pharmaceutical Associates, Inc., 100,000 units/mL, 60 mL bottle, NDC 00121-0810-02
- Nystatin oral suspension, Precision Dose, 100,000 units/mL, 5 mL container, 30 count, NDC 68094-0599-62
- Nystatin oral suspension, Precision Dose, 100,000 units/mL, 5 mL container, 100 count, NDC 68094-0599-61
- Nystatin oral suspension, Precision Dose, 100,000 units/mL, 5 mL syringe, NDC 68094-0599-58
- Nystatin oral suspension, Vista Pharma, 100,000 units/mL, 480 mL bottle, NDC 66689-0008-16
- Nystatin oral suspension, Vista Pharma, 100,000 units/mL, 5 mL container, 50 count, NDC 66689-0037-50
- Nystatin oral suspension, Vista Pharma, 100,000 units/mL, 5 mL container, 100 count, NDC 66689-0037-99
- Nystatin oral suspension, Vista Pharma, 100,000 units/mL, 60 mL bottle, NDC 66689-0008-02
- Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 473 mL bottle, NDC 60432-0537-16
- Nystatin oral suspension, Wockhardt USA, 100,000 units/mL, 60 mL bottle, NDC 60432-0537-60

Updated

Updated December 9, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 10, 2018 by Anthony Trovato, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.